Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tick-Borne Encephalitis”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Large-scale testing (Phase 3)Study completedNCT00161876
What this trial is testing

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 3,973
Testing effectiveness (Phase 2)Study completedNCT00161850
What this trial is testing

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Not applicableWithdrawnNCT03932448
What this trial is testing

Fever After Tick Bite Study

Who this might be right for
Tick-Bite; FeverTick FeverTick-Borne Diseases+2 more
Göteborg University
Post-approval studies (Phase 4)Study completedNCT00804219
What this trial is testing

Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

Who this might be right for
Tick-borne Encephalitis
Medical University of Vienna 67
Post-approval studies (Phase 4)Study completedNCT00452621
What this trial is testing

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Who this might be right for
Encephalitis, Tick-Borne
Novartis 235
Not applicableUnknownNCT02328469
What this trial is testing

Aseptic Meningoencephalitis in Slovenia

Who this might be right for
Aseptic Meningitis
University Medical Centre Ljubljana 800
Post-approval studies (Phase 4)Study completedNCT00163540
What this trial is testing

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Post-approval studies (Phase 4)Study completedNCT00461695
What this trial is testing

Influence of Persistent CMV-infection on Immune Senescence

Who this might be right for
Immune Senescence
University of Zurich 183
Not applicableStudy completedNCT00163618
What this trial is testing

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Post-approval studies (Phase 4)Study completedNCT00311441
What this trial is testing

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Who this might be right for
Encephalitis, Tick-Borne
Novartis 300
Post-approval studies (Phase 4)Study completedNCT01562444
What this trial is testing

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Who this might be right for
Tick Borne EncephalitisVirus Diseases
GlaxoSmithKline 206
Large-scale testing (Phase 3)Study completedNCT04648241
What this trial is testing

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Who this might be right for
Tick-Borne Encephalitis
Pfizer 165
Large-scale testing (Phase 3)Study completedNCT00161863
What this trial is testing

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer
Not applicableLooking for participantsNCT03956446
What this trial is testing

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Who this might be right for
Tick Borne Encephalitis
University Medical Centre Ljubljana 80
Not applicableLooking for participantsNCT03418441
What this trial is testing

Central Nervous System Infections in Denmark

Who this might be right for
Central Nervous System InfectionsBacterial MeningitisViral Meningitis+9 more
Aalborg University Hospital 1,900
Post-approval studies (Phase 4)UnknownNCT04017052
What this trial is testing

Application of a TBE-Vaccine in Obese Persons

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 73
Large-scale testing (Phase 3)Study completedNCT02318069
What this trial is testing

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 250
Next Page